Jing Cui, DSc, DABR

Assistant Professor of Clinical Radiation Oncology

Image of Jing Cui, DSc, DABR
Is this your profile? Click to edit


Dr. Cui is an Assistant Professor of Clinical Radiation Oncology-Medical Physics at USC Norris Cancer Hospital and USC + Los Angeles County Medical Center. She joined USC in July of 2014.

Dr. Cui graduated from Shanghai Jiao Tong University in China with a Bachelor of Science degree in Mechanical Engineering and Minor in Applied Mathematics. She received her doctorate degree from Washington University in St. Louis School of Engineering and Applied Science, and conducted post-doctoral research in Medical Physics at Washington University in St. Louis followed by a two-year residency in Medical Physics at UC Davis.

She was on the faculty at UC Davis during 2010-2014 specializing in medical linear accelerator commissioning, radiation beam modeling, and image-guided radiation therapy. She has presented and published multiple studies investigating computational fluid dynamics, radiation beam modeling, IGRT, and is a reviewer for multiple peer reviewed scientific journals.

Medical Physics Expertise: IGRT, Radiation Beam Modeling, SBRT, HDR

Languages Spoken: English, Mandarin


  • AAPM: AAPM Summer School Scholarship & Capintec Travel Award, 2009


  • Automatic segmentation of high-risk clinical target volume for tandem-and-ovoids brachytherapy patients using an asymmetric dual-path convolutional neural network Med Phys. 2022 Mar; 49(3):1712-1722. . View in PubMed
  • Momentum-space imaging spectroscopy for the study of nanophotonic materials Sci Bull (Beijing). 2021 Apr 30; 66(8):824-838. . View in PubMed
  • Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain J Med Chem. 2018 08 09; 61(15):6779-6800. . View in PubMed
  • Modification and validation of an analytical source model for external beam radiotherapy Monte Carlo dose calculations Med Phys. 2016 Aug; 43(8):4842. . View in PubMed
  • Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning Head Neck. 2014 Nov; 36(11):1541-6. . View in PubMed
  • Quantification of gross tumour volume changes between simulation and first day of radiotherapy for patients with locally advanced malignancies of the lung and head/neck J Med Imaging Radiat Oncol. 2014 Oct; 58(5):618-24. . View in PubMed
  • Helical tomotherapy with simultaneous integrated boost dose painting for the treatment of synchronous primary cancers involving the head and neck Br J Radiol. 2014 Aug; 87(1040):20130697. . View in PubMed
  • Dose–volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):771-7. . View in PubMed
  • Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumours Br J Radiol. 2013 Dec; 86(1032):20130459. . View in PubMed
  • Skin dose effects of postmastectomy chest wall radiation therapy using brass mesh as an alternative to tissue equivalent bolus Pract Radiat Oncol. 2013 Apr-Jun; 3(2):e45-53. . View in PubMed
  • Interfraction motion of the vaginal apex during postoperative intensity modulated radiation therapy: are we missing the target? Int J Gynecol Cancer. 2013 Feb; 23(2):385-92.. View in PubMed
  • Development of a standardized method for contouring the lumbosacral plexus: a preliminary dosimetric analysis of this organ at risk among 15 patients treated with intensity-modulated radiotherapy for lower gastrointestinal cancers and the incidence of radiation-induced lumbosacral plexopathy Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):376-82. . View in PubMed
  • Sensitivity of selected human tumor models to PF-04217903, a novel selective c-Met kinase inhibitor Mol Cancer Ther. 2012 Apr; 11(4):1036-47. . View in PubMed
  • Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):1897-902. . View in PubMed
  • MicroRT-small animal conformal irradiator Med Phys. 2007 Dec; 34(12):4706-16. . View in PubMed
  • The denoising of Monte Carlo dose distributions using convolution superposition calculations Phys Med Biol. 2007 Sep 07; 52(17):N375-85. . View in PubMed
  • An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms Cancer Res. 2007 May 01; 67(9):4408-17. . View in PubMed
  • Retrospective monte carlo dose calculations with limited beam weight information Med Phys. 2007 Jan; 34(1):334-46. . View in PubMed
  • In vivo models of proliferative vitreoretinopathy Nat Protoc. 2007; 2(1):67-77. . View in PubMed
  • Three-dimensional computation of a synthetic jet in quiescent
    air AIAA Journal. 2006; 44(12):2857-2865. . View in PubMed
  • A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo Cancer Res. 2003 Nov 01; 63(21):7345-55. . View in PubMed
  • Novel pyrrolyllactone and pyrrolyllactam indolinones as potent cyclin-dependent kinase 2 inhibitors Bioorg Med Chem Lett. 2003 Jun 02; 13(11):1939-42. . View in PubMed
  • A novel class of tests for the detection of mitochondrial DNA-mutation involvement in diseases Am J Hum Genet. 2003 Jun; 72(6):1515-26. . View in PubMed
  • Non-covalent thrombin inhibitors featuring P(3)-heterocycles with P(1)-monocyclic arginine surrogates Bioorg Med Chem Lett. 2002 Apr 22; 12(8):1203-8. . View in PubMed